Pediatric Rheumatology

Article	Citations
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches	118
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey	80
Proceedings of the 29th European Paediatric Rheumatology Congress	43
Intravenous administration of anakinra in children with macrophage activation syndrome	38
Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)	36
Growth and puberty in children with juvenile idiopathic arthritis	32
Distinguishing active pediatric COVID-19 pneumonia from MIS-C	31
NLRP12-associated systemic autoinflammatory diseases in children	27
Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases	26
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology	24
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?	22
Pediatric rheumatology in Africa: thriving amidst challenges	21
Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)	20
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab	19
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East	19
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	19
Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect	17
Epidemiology of pediatric uveitis and associated systemic diseases	17
Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases	17
Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic	17
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	16
Evaluation of pediatric rheumatology telehealth satisfaction during the COVID-19 pandemic	16
Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis	16
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER	16
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	16

Similarities and differences between MIS-C and KD: a systematic review and meta-analysis	16
Psychiatric disorders in incident patients with juvenile idiopathic arthritis - a case-control cohort study	16
Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper forms	15
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review	15
Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib	15
Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus	14
Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions	14
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review	14
Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective coho	13
Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort	13
Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials	13
Chronic nonbacterial osteomyelitis in children: a multicentre Belgian cohort of 30 children	13
Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature	12
Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series	12
Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline	12
Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study	12
A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan	12
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	12
I don’t want to think about it: a qualitative study of children (6–18 years) with rheumatic diseases and parents’ experiences with regular needle injections at home	12
Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation	12
Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis	12
Disordered eating among adolescents with chronic pain: the experience of a pediatric rheumatology subspecialty pain clinic	12
In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study	12
Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China	11
Lost bones: differential diagnosis of acro-osteolysis seen by the pediatric rheumatologist	11
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients	11
Outcomes of transitional care programs on adolescent chronic inflammatory systemic diseases: systematic review and meta-analyses	11
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review	11
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases	11
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series	11
Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort	11
Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention	11
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial	10
How children with juvenile idiopathic arthritis view participation and communication in healthcare encounters: a qualitative study	10
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	10
TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases	10
Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children	10
Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs)	10
Age, gender, height and weight in relation to joint cartilage thickness among school-aged children from ultrasonographic measurement	10
‘Snakes & Ladders’: factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis – a qualitative study	10
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach	10
Leukocytoclastic vasculitis in patients with IL12B or IL12RB1 deficiency: case report and review of the literature	9
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms	9
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	9
Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study	9
Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis	9
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	9
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents	9
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study	9
Childhood-onset primary Sjögren’s syndrome in a tertiary center in China: clinical features and outcome	9

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial	9
Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants	9
Clinical characteristics and genetic analysis of A20 haploinsufficiency	9
Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus	9
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies	9
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	9
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study	9
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	9
Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report	9
Pediatric rheumatologists’ perspectives on diagnosis, treatment, and outcomes of Sjögren disease in children and adolescents	8
IgA vasculitis nephritis clinical course and kidney biopsy – national study in children	8
Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review	8
Identifying the content and context of pain within paediatric rheumatology healthcare professional curricula in the UK: a summative content analysis	8
Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus	8
Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden	8
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	8
Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience	8
Streptococcal infection in childhood Henoch-Schönlein purpura: a 5-year retrospective study from a single tertiary medical center in China, 2015–2019	8
Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis	8
Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis	8
A novel mutation in early‐onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes	8
Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis	8
Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)	8
Home-based exercise program for adolescents with juvenile dermatomyositis quarantined during COVID-19 pandemic: a mixed methods study	8
Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis	8
Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement	7
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study	7
Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry	7
Exploring the intersection of adverse childhood experiences, pediatric chronic pain, and rheumatic disease	7
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	7
Monitoring patients with juvenile idiopathic arthritis using health-related quality of life	7
Neuropsychological functioning and academic abilities in patients with juvenile idiopathic arthritis	7
Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic	7
Bridging gaps: a qualitative inquiry on improving paediatric rheumatology care among healthcare workers in Kenya	7
Diffuse alveolar hemorrhage in children with trisomy 21	7
Glucose metabolism in systemic juvenile idiopathic arthritis	7
Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia	7
Magnetic resonance imaging findings in children with Parry-Romberg syndrome and en coup de sabre	7
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients	7
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study	7
Development and validation of the Sorting non-trauMatIc adoLescent knEe pain (SMILE) tool – a development and initial validation study	7
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis	7
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up	7
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis	7
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	7
Anasarca as the presenting symptom of juvenile dermatomyositis: a case series	7
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	7
Economic impact of Juvenile Idiopathic Arthritis: a systematic review	7
A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases	7
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis	7
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	7
Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series	7
Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)	7
Blau syndrome: a case report from Palestine	6
Suicidal risk and resilience in juvenile fibromyalgia syndrome: a cross-sectional cohort study	6
Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA	6
Disability and disease-related damage in Thai children and adolescents with juvenile idiopathic arthritis	6
Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids	6
Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence	6
Monogenic disorders as mimics of juvenile idiopathic arthritis	6
Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report	6
Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases	6
Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study	6
Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry	6
The “Intermediate” CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease	6
Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational d	6
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	6
Use of PROMIS® to screen for depression in children with arthritis	6
Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study	6
Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus	6
Homozygous variant p. Arg90His in NCF1 is associated with early-onset Interferonopathy: a case report	6
Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective	6
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	6
Monocyte platelet aggregates in children with Kawasaki disease- a preliminary study from a tertiary care centre in North-West India	6
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE	6
Revising the WHO Essential Medicines List for paediatric rheumatology	6
Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing	6
The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis	6
A novel transition clinic structure for adolescent and young adult patients with childhood onset rheumatic disease improves transition outcomes	6
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva	6

The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort	6
Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature	6
Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis	6